Back to trial details

Intake questionnaire

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Applying to Regional One · Memphis, Tennessee

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Sjögren?
3. Are you able to travel to Memphis for study visits?